14678-95-6 Usage
General Description
5-Amino-1-(4-methoxyphenyl)-1H-pyrazole is a chemical compound with the molecular formula C10H10N4O. It is a pyrazole derivative with a substituted phenyl group, and it is used in pharmaceutical research as a building block for the synthesis of various biologically active compounds. The 4-methoxyphenyl group attached to the pyrazole ring provides potential for modulating the compound's properties and activities. This chemical may have applications in the development of new drugs or therapeutic agents due to its unique structure and potential biological activity. Further research and testing are required to fully understand the potential uses and implications of 5-amino-1-(4-methoxyphenyl)-1H-pyrazole.
Check Digit Verification of cas no
The CAS Registry Mumber 14678-95-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,6,7 and 8 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 14678-95:
(7*1)+(6*4)+(5*6)+(4*7)+(3*8)+(2*9)+(1*5)=136
136 % 10 = 6
So 14678-95-6 is a valid CAS Registry Number.
InChI:InChI=1/C11H11N3O3/c1-17-8-4-2-7(3-5-8)14-10(12)9(6-13-14)11(15)16/h2-6H,12H2,1H3,(H,15,16)
14678-95-6Relevant articles and documents
Synthesis of pyrazole-carboxamides and pyrazole-carboxylic acids derivatives: Simple methods to access powerful building blocks
Ferreira, Byanca Silva,Silva, Rafaela Corrêa,Souto, Bernardo Araújo,Dos Santos, Maurício Silva
, p. 335 - 343 (2021/09/07)
Hybrid systems containing pyrazole moiety show a wide spectrum of biological activities. To access novel hybrids with pyrazole ring, in this work we synthesized twenty pyrazole-carboxylic acids and twenty pyrazole-carboxamides, using simple synthetic methods, to be used as building blocks in the development of new structures.
3-AMINO-PYRAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL AS INHIBITORS OF PROTEIN KINASES
-
Page/Page column 41, (2008/12/05)
The invention relates to novel heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them